- Home
- SYF vs BAX Comparison
SYF vs BAX Comparison
Compare SYF & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYF
- BAX
- Stock Information
- Founded
- SYF 1932
- BAX 1931
- Country
- SYF United States
- BAX United States
- Employees
- SYF N/A
- BAX N/A
- Industry
- SYF Finance: Consumer Services
- BAX Medical/Dental Instruments
- Sector
- SYF Finance
- BAX Health Care
- Exchange
- SYF Nasdaq
- BAX Nasdaq
- Market Cap
- SYF 19.4B
- BAX 15.6B
- IPO Year
- SYF N/A
- BAX N/A
- Fundamental
- Price
- SYF $61.41
- BAX $33.85
- Analyst Decision
- SYF Buy
- BAX Hold
- Analyst Count
- SYF 22
- BAX 10
- Target Price
- SYF $66.45
- BAX $38.80
- AVG Volume (30 Days)
- SYF 4.3M
- BAX 4.7M
- Earning Date
- SYF 01-28-2025
- BAX 02-20-2025
- Dividend Yield
- SYF 1.63%
- BAX 2.01%
- EPS Growth
- SYF 64.74
- BAX N/A
- EPS
- SYF 8.55
- BAX N/A
- Revenue
- SYF $9,392,000,000.00
- BAX $10,636,000,000.00
- Revenue This Year
- SYF N/A
- BAX N/A
- Revenue Next Year
- SYF $7.81
- BAX $6.55
- P/E Ratio
- SYF $7.18
- BAX N/A
- Revenue Growth
- SYF 22.58
- BAX N/A
- 52 Week Low
- SYF $39.67
- BAX $28.34
- 52 Week High
- SYF $70.93
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- SYF 33.47
- BAX 67.87
- Support Level
- SYF $63.31
- BAX $30.56
- Resistance Level
- SYF $65.97
- BAX $31.71
- Average True Range (ATR)
- SYF 2.09
- BAX 0.66
- MACD
- SYF -0.53
- BAX 0.21
- Stochastic Oscillator
- SYF 4.72
- BAX 96.00
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.